Literature DB >> 3977716

Spondyloepiphyseal dysplasia congenita. Light and electron microscopic studies of the eye.

T G Murray, W R Green, I H Maumenee, S E Kopits.   

Abstract

A 5-month-old infant with spondyloepiphyseal dysplasia congenita (SEDC) died after an anoxic episode. Ophthalmologic examination one month before death revealed marked myopia and a normal ophthalmoscopic examination, without evidence of retinal detachment, lattice degeneration, or vitreoretinal changes. On postmortem histopathologic and electron microscopic examination of the eyes, we found the vitreous to have central liquefaction, to be detached in multifocal areas, and exerting traction on the retina. The internal limiting membrane of the retina was thin throughout and displayed many areas of discontinuity. There were multiple areas of preretinal cellular proliferation and a few small areas of retinoschisis. Our observation of extensive vitreoretinal degeneration with traction of the retina indicates that eyes of patients with SEDC are at an increased risk for the development of retinal detachment.

Entities:  

Mesh:

Year:  1985        PMID: 3977716     DOI: 10.1001/archopht.1985.01050030103032

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Association of spondylo-epiphyseal dysplasia with nephrotic syndrome.

Authors:  J H Ehrich; G Offner; E Schirg; P F Hoyer; U Helmchen; J Brodehl
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

2.  Spondyloepiphyseal dysplasia congenita: genetic linkage to type II collagen (COL2AI).

Authors:  I J Anderson; R B Goldberg; R W Marion; W B Upholt; P Tsipouras
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

3.  Involvement of the Retinal Pigment Epithelium in the Development of Retinal Lattice Degeneration.

Authors:  Hiroshi Mizuno; Masanori Fukumoto; Takaki Sato; Taeko Horie; Teruyo Kida; Hidehiro Oku; Kimitoshi Nakamura; Denan Jin; Shinji Takai; Tsunehiko Ikeda
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.